Status:

TERMINATED

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Lead Sponsor:

Alkermes, Inc.

Conditions:

Alcoholism

Opiate Dependence

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This was a multicenter extension of Alkermes' Study ALK21-006 (NCT01218997) designed to assess the long-term safety of repeat monthly doses of naltrexone long-acting injection. All subjects received o...

Detailed Description

From the date of successful completion of Study ALK21-006 (base study \[NCT01218997\])), all subjects, including those who received oral naltrexone during the base study, were given the option to enro...

Eligibility Criteria

Inclusion

  • Primary
  • Adults with a diagnosis of alcohol and/or opioid dependence as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) who had satisfactorily completed Alkermes' Study ALK21-006 or other qualifying Medisorb naltrexone study
  • Willing and able to return for scheduled clinic visits and study assessments
  • Had a stable address
  • Agreed to use a contraception for the duration of the study and for 1 month following the last dose if of childbearing potential
  • Written informed consent
  • Primary

Exclusion

  • Pregnancy or lactation
  • Terminated early from study drug in a previous Medisorb naltrexone clinical trial
  • Any finding that, in the view of the investigator, would compromise the ability to fulfill the protocol visit schedule and/or visit requirements

Key Trial Info

Start Date :

August 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2007

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT00156936

Start Date

August 1 2004

End Date

January 1 2007

Last Update

November 17 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) | DecenTrialz